Mipox Past Earnings Performance
Past criteria checks 0/6
Mipox has been growing earnings at an average annual rate of 26.4%, while the Chemicals industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 7.1% per year.
Key information
26.4%
Earnings growth rate
29.4%
EPS growth rate
Chemicals Industry Growth | 6.6% |
Revenue growth rate | 7.1% |
Return on equity | -5.5% |
Net Margin | -4.4% |
Next Earnings Update | 09 Aug 2024 |
Recent past performance updates
Recent updates
The Price Is Right For Mipox Corporation (TSE:5381) Even After Diving 38%
Aug 05Mipox (TSE:5381) Is Carrying A Fair Bit Of Debt
Aug 03Sentiment Still Eluding Mipox Corporation (TSE:5381)
Feb 27We Think Mipox (TYO:5381) Is Taking Some Risk With Its Debt
Mar 14Mipox (TYO:5381) Has Gifted Shareholders With A Fantastic 147% Total Return On Their Investment
Feb 06Mipox Corporation (TYO:5381) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Jan 02Revenue & Expenses Breakdown
How Mipox makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 9,354 | -408 | 2,788 | 122 |
31 Dec 23 | 8,920 | -489 | 2,802 | 133 |
30 Sep 23 | 8,886 | -939 | 2,831 | 133 |
30 Jun 23 | 9,070 | -423 | 2,843 | 133 |
31 Mar 23 | 10,029 | 45 | 3,008 | 133 |
31 Dec 22 | 10,340 | 635 | 3,241 | 48 |
30 Sep 22 | 10,864 | 1,486 | 3,236 | 48 |
30 Jun 22 | 10,687 | 1,475 | 3,181 | 48 |
31 Mar 22 | 10,449 | 1,550 | 2,962 | 48 |
31 Dec 21 | 9,986 | 1,244 | 2,675 | 70 |
30 Sep 21 | 8,937 | 720 | 2,436 | 70 |
30 Jun 21 | 8,289 | 515 | 2,234 | 70 |
31 Mar 21 | 7,361 | 87 | 2,154 | 70 |
31 Dec 20 | 6,909 | 62 | 2,093 | 55 |
30 Sep 20 | 7,100 | 78 | 2,135 | 55 |
30 Jun 20 | 7,219 | -47 | 2,211 | 55 |
31 Mar 20 | 7,338 | -78 | 2,235 | 55 |
31 Dec 19 | 7,465 | -1,172 | 2,303 | 81 |
30 Sep 19 | 7,468 | -1,107 | 2,321 | 81 |
30 Jun 19 | 7,600 | -1,105 | 2,376 | 81 |
31 Mar 19 | 7,558 | -967 | 2,311 | 81 |
31 Dec 18 | 7,514 | -28 | 2,241 | 33 |
30 Sep 18 | 7,698 | 117 | 2,208 | 33 |
30 Jun 18 | 7,643 | 202 | 2,206 | 33 |
31 Mar 18 | 7,826 | 265 | 2,206 | 33 |
31 Dec 17 | 7,851 | 270 | 2,221 | 54 |
30 Sep 17 | 7,597 | 304 | 2,219 | 54 |
30 Jun 17 | 7,284 | 30 | 2,253 | 54 |
31 Mar 17 | 6,410 | -147 | 2,048 | 54 |
31 Dec 16 | 5,607 | -215 | 1,916 | 14 |
30 Sep 16 | 4,671 | -350 | 1,731 | 14 |
30 Jun 16 | 4,125 | 84 | 1,500 | 14 |
31 Mar 16 | 4,204 | 323 | 1,523 | 14 |
31 Dec 15 | 4,318 | 546 | 1,537 | 19 |
30 Sep 15 | 4,388 | 688 | 1,467 | 19 |
30 Jun 15 | 4,188 | 619 | 1,338 | 19 |
31 Mar 15 | 3,985 | 508 | 1,284 | 19 |
31 Dec 14 | 3,781 | 438 | 1,228 | 14 |
30 Sep 14 | 3,891 | 348 | 1,223 | 14 |
30 Jun 14 | 3,837 | 219 | 1,231 | 14 |
31 Mar 14 | 3,760 | 230 | 1,198 | 14 |
31 Dec 13 | 3,709 | 115 | 1,200 | 26 |
30 Sep 13 | 3,369 | 56 | 1,155 | 26 |
Quality Earnings: 5381 is currently unprofitable.
Growing Profit Margin: 5381 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 5381 is unprofitable, but has reduced losses over the past 5 years at a rate of 26.4% per year.
Accelerating Growth: Unable to compare 5381's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 5381 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (9.7%).
Return on Equity
High ROE: 5381 has a negative Return on Equity (-5.45%), as it is currently unprofitable.